Comprehensive hereditary breast cancer risk testing menu, including BRCA1 and BRCA2, and expanded testing for significant breast cancer susceptibility genes.
Are your patients at risk of chlamydia and gonorrhea infection? Find out why It's Best to Test.
See the Sensitivity and Specificity sections at Aptimaforher.com to learn more about Aptima® HPV mRNA performance.
“Advances in Cervical Cancer Screening and A New Approach to the Pelvic Mass,”
Darren Wheeler, MD discusses recent advances regarding HPV and Pap co-testing, emerging technologies and clinical approaches.
Female testosterone testing
Jon Nakamoto, MD, PhD compares and contrasts current testosterone assays and discusses appropriate testosterone testing for female patients. Video includes clinical case studies on a variety of conditions.
Test Interpretation Guides
See our guides for details on test selection, utilization and interpretation. All information is based on peer-reviewed publications and practice guidelines.